Showing results (1-10 of 433) with videos related to
Sort By:
Pageof 44
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1994
[Microtubules and antineoplastic drugs]H Arioka, N SaijoGan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1997
[Apoptosis and chemosensitivity]K Nishio, H Arioka, N SaijoJournal of Cancer Research and Clinical Oncology|January 1, 1997
In vitro and in vivo modulation by rhizoxin of non-P-glycoprotein-mediated vindesine resistanceH Arioka, K Nishio, Y Heike, et al.Japanese Journal of Cancer Research : Gann|February 1, 1995
Correlation of gene-specific damage with cisplatin between human adenocarcinoma cells and peripheral blood mononuclear cells analyzed by polymerase chain reaction-stop assayF Oshita, H Arioka, Y Heike, et al.Japanese Journal of Cancer Research : Gann|January 24, 1998
In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cellsH Ogasawara, K Nishio, T Ishida, et al.International Journal of Cancer|November 27, 1995
Enhanced interaction between tubulin and microtubule-associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxelK Nishio, H Arioka, T Ishida, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID miceY Heike, M Takahashi, T Ohira, et al.Biochemical and Biophysical Research Communications|November 2, 1995
Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistanceH Kurokawa, T Ishida, K Nishio, et al.Japanese Journal of Cancer Research : Gann|February 1, 1997
Effect of glutathione depletion on cisplatin resistance in cancer cells transfected with the gamma-glutamylcysteine synthetase geneH Kurokawa, K Nishio, T Ishida, et al.Japanese Journal of Cancer Research : Gann|July 28, 2001
Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6Y Tatsumi, H Arioka, S Ikeda, et al.Pageof 44